FDA grants breakthrough designation to daridorexant following 50-minute sleep improvement in children
Idorsia's daridorexant gains FDA breakthrough status after improving sleep in children. Discover Phase 2 findings and upcoming Phase 3 plans.
Pharma & Biotech